Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 36: | Line 36: | ||
* [[Sutent]] - Generic: [[Sunitinib]] | * [[Sutent]] - Generic: [[Sunitinib]] | ||
* [[Tasigna]] - Generic: [[Nilotinib]] | * [[Tasigna]] - Generic: [[Nilotinib]] | ||
| + | * [[Ibrutinib]] - brand name: [[Imbruvica]] | ||
=====[[Vascular Endothelial Growth Factor]] Inhibitor===== | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== | ||
* [[Avastin]] - Generic: [[Bevacizumab]] | * [[Avastin]] - Generic: [[Bevacizumab]] | ||
Revision as of 13:27, 8 October 2023
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
mTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
